Anzeige
Mehr »
Donnerstag, 15.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 932242 | ISIN: IE0005711209 | Ticker-Symbol: IJF
Tradegate
15.05.25 | 15:36
117,00 Euro
-1,22 % -1,45
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ICON PLC Chart 1 Jahr
5-Tage-Chart
ICON PLC 5-Tage-Chart
RealtimeGeldBriefZeit
115,80116,5016:28
115,80116,5016:28

Aktuelle News zur ICON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.05.ICON plc: Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies191ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across...
► Artikel lesen
30.04.ICON plc: ICON Reports First Quarter 2025 Results386Highlights Net business wins in the quarter of $2,022 million; a net book to bill in the quarter of 1.01. Closing backlog of $24.7 billion, an increase of 0.3% on quarter four 2024 and...
► Artikel lesen
30.04.ICON PLC - 6-K, Report of foreign issuer2
27.04.ICON Public Limited Company (ICLR): Among the Oversold Growth Stocks to Buy Now7
10.04.What Makes Icon PLC (ICLR) an Investment Bet?10
ICON Aktie jetzt für 0€ handeln
03.04.LVS Advisory Sold Icon Plc (ICLR) After Identifying Flaws in its Investment Thesis10
31.03.ICON plc Schedules First Quarter 2025 Earnings Conference Call324ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the first quarter 2025...
► Artikel lesen
31.03.ICON PLC - 6-K, Report of foreign issuer2
24.03.ICON Public Limited Company (ICLR) Leverages AI-Powered Medidata Platform to Optimize Clinical Trials4
19.03.ICON Public Limited Company (ICLR) Slid on Disappointing Earnings4
12.03.ICON PLC - 6-K, Report of foreign issuer2
07.03.ICON Public Limited Company (ICLR): A Bull Case Theory4
05.03.ICON plc to Present at Upcoming Investor Conferences271ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Leerink Partners...
► Artikel lesen
04.03.Mural Health, ICON Partner to Enhance Site Experience in Clinical Trials2
04.03.Mural Health and ICON plc Announce Partnership to Enhance Participant and Site Experience in Clinical Trials372BERWYN, Pa. and DUBLIN, March 4, 2025 /PRNewswire/ -- Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence...
► Artikel lesen
03.03.ICON PLC - 6-K, Report of foreign issuer4
21.02.ICON PLC - 20-F, Annual and transition report of foreign private issuers1
20.02.ICON Public targets 1.2x book-to-bill ratio in 2025 amid strategic partnership growth2
20.02.ICLR Q4 Earnings and Revenues Beat, Stock Rises at After-Market5
19.02.ICON plc: ICON Reports Fourth Quarter and Full Year 2024 Results541Highlights Net business wins in the quarter of $2,413 million; a net book to bill in the quarter of 1.18. Full year net business wins of $9,974 million; a net book to bill of 1.20. Closing...
► Artikel lesen
Seite:  Weiter >>
55 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1